Situation: CMS, under the Trump administration, has put Medicare Advantage operational integrity back at the center of the VBC agenda with a proposed rule aimed at improving MA provider directory accuracy, increasing PBM transparency, and reducing prescription drug costs. The AHA flagged the proposal as a material compliance and affordability development for plans and providers, particularly because the directory provisions would apply to network-based MA plans and begin taking effect in 2028 (AHA brief). Healthcare Dive’s coverage emphasizes that CMS is moving to operationalize healthcare provisions from the February funding package, with the reforms squarely tied to beneficiary navigation, pharmacy economics, and plan accountability (CMS proposal).

At the same time, the market is showing stress: reporting from Iowa indicates 87,000 Medicare Advantage members face plan cancellations, underscoring how benefit redesign, county exits, and network economics are now colliding with consumer expectations during annual enrollment. The immediate signal is clear: MA is becoming less forgiving for plans that cannot prove network adequacy, pharmacy value, and administrative reliability. This is a direct hit to Healthcare Affordability, Medicare Payment Policy, and Health IT & Interoperability.

Background: The proposed CMS rule lands in a market already recalibrating around tighter margins, higher utilization, Star Ratings pressure, and sharper scrutiny of risk adjustment, supplemental benefits, prior authorization, and network access. Provider directories are not a clerical issue in value-based care; they are the front door to attribution, referral management, access standards, and member experience. If beneficiaries cannot identify an in-network physician, the value proposition of MA deteriorates quickly. HFMA’s summary of the proposed 2028 directory requirements reinforces that CMS is treating directory accuracy as a structural requirement, not a consumer-service nicety (HFMA analysis).

The PBM transparency provisions matter just as much. Drug affordability is now inseparable from total-cost-of-care performance, especially in risk-bearing arrangements where pharmacy trend can erase medical savings. The Aledade explainer on Traditional Medicare vs. Medicare Advantage is a useful reminder that these models differ not only in benefit structure, but in how accountability, networks, and financial risk are organized (Aledade explainer). For executives, the relevant frame is not “MA versus fee-for-service”; it is whether plan-provider partnerships can deliver measurable access, affordability, and outcomes under growing regulatory pressure across Value-Based Contracting.

Assessment: The direction of travel is unmistakable: CMS is shifting MA oversight from benefit richness to operational proof. The plans most exposed are those relying on narrow networks, stale directories, opaque pharmacy economics, and weak provider data infrastructure. The providers most exposed are those entering downside-risk or delegated arrangements without clean rosters, referral leakage controls, and real-time access data.

This also changes the competitive math for Special Needs Plans and integrated Medicare-Medicaid models. Modern Healthcare’s reporting on SNPs as MA’s next growth engine suggests plans are looking to complex, high-need populations for margin and differentiation, but those populations require exactly the capabilities CMS is now scrutinizing: accurate networks, coordinated referrals, medication affordability, and reliable care management. Rhode Island’s procurement for up to three plans in an integrated Medicare-Medicaid program further points to state and federal convergence around accountable care for dual-eligible populations (RI procurement).

My read: this is not just a compliance cycle. It is a capability test. Organizations that treat directory accuracy, PBM transparency, prior authorization modernization, and care navigation as separate workstreams will underperform. The winners will build a unified operating model across Care Coordination & Referrals, contracting, data exchange, and member experience.